Aziz Sawaf Theravance Biopharma, Inc. (TBPH) insider trading activity

Aziz Sawaf is SVP & CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc.. Currently has a direct ownership of 364,790 shares of TBPH, which is worth approximately $4.02 Million. The most recent transaction as insider was on May 20, 2025, when has been sold 9,348 shares (Ordinary Shares) at a price of $9.45 per share, resulting in proceeds of $88,338. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 365K

2.5% 3M change

10.54% 12M change

Total Value Held $4.02 Million

Aziz Sawaf Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	SELL Payment of exercise price or tax liability	$88,338 $9.45 p/Share	9,348 Reduced 2.5%	364,790 Ordinary Shares
Feb 28 2025	BUY Grant, award, or other acquisition	-	75,000 Added 16.7%	374,138 Ordinary Shares
Feb 20 2025	SELL Payment of exercise price or tax liability	$132,834 $9.66 p/Share	13,751 Reduced 4.39%	299,138 Ordinary Shares
Nov 20 2024	SELL Payment of exercise price or tax liability	$84,515 $9.97 p/Share	8,477 Reduced 2.64%	312,889 Ordinary Shares
Aug 20 2024	SELL Payment of exercise price or tax liability	$70,979 $8.22 p/Share	8,635 Reduced 2.62%	321,366 Ordinary Shares
May 20 2024	SELL Payment of exercise price or tax liability	$78,578 $9.1 p/Share	8,635 Reduced 2.55%	330,001 Ordinary Shares
Apr 02 2024	BUY Grant, award, or other acquisition	-	100,000 Added 22.8%	338,636 Ordinary Shares
Feb 20 2024	SELL Payment of exercise price or tax liability	$151,961 $8.92 p/Share	17,036 Reduced 6.66%	238,636 Ordinary Shares
Nov 20 2023	SELL Payment of exercise price or tax liability	$64,159 $10.37 p/Share	6,187 Reduced 2.36%	255,672 Ordinary Shares
Aug 20 2023	SELL Payment of exercise price or tax liability	$69,005 $9.7 p/Share	7,114 Reduced 2.64%	261,859 Ordinary Shares
May 20 2023	SELL Payment of exercise price or tax liability	$98,020 $11.21 p/Share	8,744 Reduced 3.15%	268,973 Ordinary Shares
Mar 01 2023	BUY Grant, award, or other acquisition	-	80,000 Added 22.36%	277,717 Ordinary Shares
Feb 20 2023	SELL Payment of exercise price or tax liability	$70,814 $10.44 p/Share	6,783 Reduced 3.32%	197,717 Ordinary Shares

Aziz Sawaf

SVP & CHIEF FINANCIAL OFFICER

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Value

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH

Account